Catalyst Wire Dossier Catalyst Wire Dossier

BILPREVDA

DENOSUMAB · Organon LLC
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for BILPREVDA, covering 2025-08-29 to 2026-08-27. Get the full timeline:

Most recent: EMA Authorised: Bilprevda (denosumab) — Sciencepharma Sp. z o.o

See pricing